These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection Initial U.S. Approval: 2002
diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection
SY
17
These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection Initial U.S. Approval: 2002
Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 5 MCG / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 5 MCG / Bordetella pertussis pertactin vaccine, inactivated 3 MCG / Bordetella pertussis toxoid vaccine, inactivated 10 MCG / diphtheria toxoid vaccine 15 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injection
SY
17
These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection Initial U.S. Approval: 2002
DTaP (diphtheria toxoid vaccine, inactivated 15 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 23 MCG) per 0.5 ML Injection
SY
17
These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection Initial U.S. Approval: 2002
These highlights do not include all the information needed to use DAPTACEL safely and effectively. See full prescribing information for DAPTACEL. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection Initial U.S. Approval: 2002